1. Home
  2. FORR vs BHST Comparison

FORR vs BHST Comparison

Compare FORR & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forrester Research Inc.

FORR

Forrester Research Inc.

N/A

Current Price

$6.37

Market Cap

106.6M

ML Signal

N/A

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

N/A

Current Price

$4.28

Market Cap

104.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
FORR
BHST
Founded
1983
2007
Country
United States
Canada
Employees
N/A
87
Industry
Diversified Commercial Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
106.6M
104.2M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
FORR
BHST
Price
$6.37
$4.28
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$12.00
AVG Volume (30 Days)
202.9K
22.1K
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$116.40
Revenue Next Year
$1.38
$55.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.91
$4.10
52 Week High
$11.57
$12.80

Technical Indicators

Market Signals
Indicator
FORR
BHST
Relative Strength Index (RSI) 47.40 37.69
Support Level $5.02 $4.27
Resistance Level $8.36 $5.02
Average True Range (ATR) 0.42 0.26
MACD 0.12 -0.02
Stochastic Oscillator 78.10 19.53

Price Performance

Historical Comparison
FORR
BHST

About FORR Forrester Research Inc.

Forrester Research Inc provides independent research, data, and advisory services. It operates through the following segments: The Research segment develops and delivers research, connect, and analytics products; The consulting segment includes the revenues and the related costs of the company's consulting organization, and the Events segment is engaged in developing and hosting in-person and virtual events.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: